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In this study, we report the host genetic responses that characterize Trypanosoma cruzi-induced myocarditis in a murine model of
infection and disease development. The mRNA species from the myocardium of infected mice were assessed using cDNA microarray
technology at immediate early, acute, and chronic stages of infection. The immediate early reaction of the host to T. cruzi infection was
marked by up-regulation of transcripts indicative of proinflammatory and interferon-induced immune responses. Following acute infection,
overexpression of transcripts for extracellular matrix (ECM) proteins, possibly initiated in response to myocardial injuries by invading and
replicating parasites, was suggestive of active reparative and remodeling reactions. Surprisingly, progression to the cardiac disease phase was
associated with coordinated down-regulation of a majority (>70%) of the differentially expressed genes. Among the most repressed genes
were the troponins, essential for contractile function of the myofibrils, and the genes encoding components of oxidative phosphorylation
(OXPHOS) pathways. Reverse transcription-polymerase chain reaction (RT-PCR), Western blotting, and biochemical assays confirmed the
microarray results and provided evidence for the deficiency of OXPHOS complex IV in the chagasic murine heart. We discuss the apparent
role of OXPHOS dysfunction in the cardiac hypertrophic and remodeling processes with the development of chagasic cardiomyopathy
(CCM).D 2003 Elsevier Science B.V. All rights reserved.Keywords: Animal model of human disease; Chagasic cardiomyopathy; Cytochrome c oxidase; Gene expression analysis; Oxidative phosphorylation;
Oxidative stress
1. Introduction sion of myocarditis, eventually leading to heart failure andChagasic cardiomyopathy (CCM), a major health prob-
lem in southern parts of the American Continent, is caused
by Trypanosoma cruzi [1]. Following infection, the acute
phase encompasses peak blood and tissue parasitemia. A
significant number of infected individuals (f 40%) then
enter the quiescent phase, where hosts remain serologically
positive, but disease-free for the rest of their lives. In others,
the indeterminate phase is associated with a slow progres-0925-4439/03/$ - see front matter D 2003 Elsevier Science B.V. All rights reserv
doi:10.1016/S0925-4439(03)00060-7
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The relationships among T. cruzi infection, host re-
sponses, and disease development are very complex. During
the acute infection phase, frequent parasitic lesions associ-
ated with extensive inflammatory infiltrates, cellular injury,
and cell death are observed in all organs and tissues of the
infected host [3–9]. The heart, however, is the major target
organ where progressive evolution of CCM is associated
with profound structural and functional alterations of the
myocardium [10]. Standard histological analyses of tissue
biopsies obtained from chagasic patients undergoing heart
transplantation or tissues from human cadavers that
exhibited evidence of CCM usually reveal mild-to-severe
inflammation, extensive tissue necrosis or fibrosis, anded.
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information is available on the cellular and molecular
mechanisms by which cardiovascular structure and func-
tions are adversely affected in T. cruzi-infected patients and
experimental models.
Recent studies have provided some details in elucidating
the host cellular responses induced in response to acute T.
cruzi infection. T. cruzi can replicate and survive in all cell
types, and is in general considered a silent parasite that
elicits few changes in the host fibroblasts during invasion
and infection processes [11]. In macrophages, the NFnB
signaling pathway is activated in response to phagocytosis
of T. cruzi [12]. Though not directly demonstrated, NFnB-
regulated transcription of cytokine genes is proposed to
induce proinflammatory responses in infected macrophages
[12]. Subsequent studies have demonstrated the importance
of the proinflammatory cytokines (e.g. TNF-a, IL-1 and IL-
6) and chemokines (e.g. IP-10, MCP-1, MIG, and
RANTES) as key regulators of the innate and adaptive
immune responses responsible for the control of acute
infection [13,14]. Interestingly, glycosylphosphatidylinosi-
tol and mucins, abundantly expressed by the infective and
intracellular stages of the parasite, have been characterized
as the prime inducers of the proinflammatory cytokines and
chemokines in the host macrophages [15–17].
Others have documented the induction of endothelin-1
(ET-1), a potent vasoconstrictor, during the acute infection
phase and its adverse effects on the host myocardium. In a
susceptible murine model of T. cruzi infection, where a
majority of infected mice succumbed within 20 days post-
infection (dpi), the plasma levels of ET-1 peaked just before
the animal’s death [18,19]. Corresponding to this increase in
ET-1 expression, T. cruzi-infected mice exhibited a sub-
stantial increase in cardiac tissue inflammation, fibrosis, and
microvascular spasms. These responses could be reversed
upon treatment with ET-1 inhibitors, suggesting the partic-
ipation of ET-1 in stimulating hypertrophic and other
reactions. ET-1 is proposed to mediate its effects through
the activation of the mitogen-activated protein kinase
(MAPK) pathway and subsequent proliferation of smooth
muscle cells [19].
The host genetic elements that change with progression
from the acute infection phase to the development of
chagasic myocarditis have, however, remained largely
unknown. Microarray technology has revolutionized the
field of molecular biology and afforded the opportunity to
profile the expression of thousands of genes. In this study,
we have used cDNA microarrays and a murine model of T.
cruzi infection to expand the repertoire of host genes that
change during the course of T. cruzi infection and disease
development. C3H/HeN (male) mice infected with T. cruzi
(SylvioX10/4 strain) trypomastigotes mimick the symptoms
of human CCM and provide an excellent model system to
monitor changes associated with the development of chronic
disease. A total of 1176 cDNAs arrayed on nylon mem-
branes were profiled for expression changes in the heart ofmice at different stages of infection and disease develop-
ment. The differentially expressed genes were sorted
according to their functional characteristics in the context
of the infection. Here, we report the down-regulation of
several of the transcripts encoding components of the
mitochondrial oxidative phosphorylation (OXPHOS) path-
way in T. cruzi-infected murine hearts and discuss their
possible role in the development of chagasic myocarditis.2. Materials and methods
2.1. Mice and parasites
Six- to eight-week-old male C3H/HeN mice were pur-
chased from Harlan (Indianapolis, IN). T. cruzi (Sylvio X10/
4 strain) and C2C12 cells (murine skeletal muscle cell line)
were purchased from American Type Culture Collection
(Manassas, VA). T. cruzi trypomastigotes were maintained
and propagated by the continuous in vitro passage of para-
sites in monolayers of C2C12 cells [20]. Mice were infected
by intraperitoneal injection of 1 million culture-derived
trypomastigotes.
2.2. Preparation of DNA
Blood and tissue samples were harvested from normal
and infected mice at weekly intervals (3 mice/time point/
group), till 50 dpi and at monthly intervals thereafter. Blood
samples were diluted 1:1 with GE buffer (6 M guanidine
HCl, 0.2 M EDTA, pH 8.0), immediately boiled for 10 min,
and stored at 4 jC [21]. Total DNA from blood-GE samples
was extracted by phenol–chloroform method [22]. Briefly,
200 Al of blood-GE sample was mixed with an equal
volume of phenol/chloroform/isoamylalcohol (24:24:1),
vortexed, and centrifuged at 12,000 g for 5 min. The
top aqueous phase was transferred to a clean 1.5-ml eppen-
dorf tube, mixed with 1/10th volume of sodium acetate (3
M, pH 5.2) and 2.5 volume of ice-cold 100% ethanol. After
centrifugation at 12,000 g for 30 min at 4 jC, the pellet
was washed with 70% alcohol and resuspended in 20-Al
distilled water.
For the extraction of DNA from the heart and skeletal
muscle, 50 mg of the finely chopped tissues were incubated
in 250-Al lysis buffer (50 mM Tris HCl, pH 7.5 containing
0.5% SDS, 10 mM EDTA, 0.1 M NaCl, and 400 Ag/ml
Proteinase K) at 55 jC for 4 h. Tissue lysates were extracted
with phenol/chloroform/isoamylalcohol (24:24:1) and DNA
purified by ethanol precipitation (as above). All genomic
DNA samples were suspended in 100-Al distilled H2O.
2.3. Parasite detection by polymerase chain reaction (PCR)
To evaluate the parasite burden, 2 Al of the total DNA,
isolated from blood or tissue samples, was amplified by PCR
in a 50-Al reaction volume using T. cruzi 18S rDNA-specific
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and elongation steps were performed for a total of 28 cycles,
for 1 min each at 94, 58, and 72 jC, respectively. A 10-Al
aliquot of each PCR reaction was electrophoresed on 1.2%
agarose gels, stained with ethidium bromide, and densito-
metric analysis performed on a FluorChem Imaging System
(Alpha Innotech, San Leandro, CA).
2.4. Histology
Some mice (three mice per group) were sacrificed at
various time intervals post-infection for histological exami-
nation. The heart and skeletal muscle tissue were removed
and fixed in 10% buffered formalin for 24 h, dehydrated in
absolute ethanol, cleared in xylene, and embedded in
paraffin. Sections (5 Am) were stained with hematoxylin
and eosin and evaluated by light microscopy. The parasite
foci were quantitated, based upon the number of parasitic
pseudocysts present in sections of the heart and skeletal
muscle obtained from infected mice at various stages of
infection and disease development. Tissues were also scored
0 to 4 in blind studies according to the extent of inflamma-
tion and tissue damage from normal to total wall involve-
ment [23,24].
2.5. RNA extraction and cDNA probes
Each excised heart was cut into pieces, flash-frozen in
liquid nitrogen, and stored at  80 jC. The frozen tissues
were individually transferred into guanidine–phenol solu-
tion, processed with a tissue homogenizer, and the total
RNA was isolated as described [25,26]. All RNA samples
were stored at  80 jC until further use.
To remove the DNA that might be contaminating the RNA
preparation, DNase treatment of total RNA was performed
using a RNA purification kit (Ambion, Austin, TX). The
[32P]-labeled cDNA probe was then generated by reverse
transcription of 5 Ag of total RNA using a gene-specific CDS
primer mix (Clontech, Palo Alto, CA) and superscript reverse
transcriptase (Life Technologies, Gaithersburg, MD) in the
presence of 5 Al of [a32P] dATP (3000 ACi/mmol, 10 ACi/Al,
Amersham, Piscataway, NJ). The labeled cDNA probe was
purified from unincorporated [32P]-labeled nucleotides and
small ( < 0.1 kb) cDNA fragments using nucleospin extrac-
tion chromatography (Clontech), and the specific activity of
the labeled probe was determined on LS 6500 liquid scintil-
lation counter (Beckman, Fullerton, CA).
2.6. Microarray hybridization and data analysis
Atlas mouse 1.2 II array kits from Clontech were used for
analysis of large-scale gene expression in control and T.
cruzi-infected mouse hearts. The materials provided with the
kit were used and the recommended protocol was followed
for pre-hybridization, cDNA probe hybridization, and wash-
ing of the membranes. Membranes were exposed to aphosphorimaging screen for 3–5 days. The images obtained
on the phosphorimaging screen were captured using a Storm
860 phosphorimager (Molecular Dynamics, Sunnyvale, CA)
and analyzed with AtlasImage 2.1 software (Clontech).
Results from triplicate experiments were averaged, and
clones with discordant or absent results were discarded.
Genes that increased or decreased in infected murine hearts
in comparison to the age-matched controls by at least 1.8-
fold were considered differentially expressed. Hierarchical
clustering of the differentially expressed genes was done
using Spotfire (Spotfire Inc., Somerville, MA), and Cluster
and TreeView software [27,28].
2.7. Semiquantitative reverse transcription-polymerase
chain reaction (RT-PCR) analyses
To validate the microarray results, we examined the
differential expression of selected genes by RT-PCR. First
strand cDNAwas synthesized by incubation of total RNA (2
Ag) extracted from heart sections of normal and infected
mice with 2.5-U MuMLV reverse transcriptase (Invitrogen,
Carlsbad, CA) and oligo-dT16 at 42 jC for 50 min in 20-Al
reaction volume. Subsequently, 0.5 Al of the cDNA was
amplified for 28 cycles by PCR using 2.5 U of Taq
polymerase and 200-ng gene-specific primer pair (listed in
Table 2), in a 50-Al reaction volume. Individual amplicons
(10 Al) were electrophoresed in agarose gels and densito-
metric analysis conducted as above.
2.8. Immunoblot analysis
Heart tissue from normal and infected mice were washed
with ice-cold Tris–HCl (10 mM, pH 7.5), and homogenized
in lysis buffer (10 mM Tris, pH 7.5, 1% Nonidet P40, 0.5%
SDS, 5 mM EDTA, 1 mM phenylmethylsulfonyl fluoride,
10 Ag/ml leupeptin, 37 Ag/ml n-alpha-tosyl-l-lysine chlor-
omethyl ketone, and 10 Ag/ml aprotinin). After incubation
for 15 min on ice, homogenates were centrifuged at
5000 g, 4 jC, for 20 min and the supernatants stored at
80 jC. Proteins were resolved on a 12% SDS-polyacry-
lamide gel and transferred to PVDF membrane (BioRad,
Hercules, CA). Membranes were washed with PBS (137
mM NaCl, 8 mM KCl, 2 mM KH2PO4, 10 mM Na2HPO4),
blocked with PBS/0.1% Tween 20 (PBST) containing 5%
nonfat dry milk (NFDM) for 1 h at room temperature, and
incubated with mouse monoclonal antibodies to cytochrome
c oxidase subunits 7aH, 7aL, or anti-h-actin antibody for 2 h
in blocking buffer. After incubation with alkaline phospha-
tase conjugated secondary antibody, color was developed
using 5-bromo-4-chloro-3-indolyl phosphate/nitroblue tetra-
zolium reagents (BioRad).
2.9. Cytochrome c oxidase activity
Mitochondria were isolated from normal and infected
murine hearts as described [29] with slight modifications.
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isolation buffer (5 mM HEPES, pH 7.2 containing 210
mM mannitol, 70 mM sucrose, 1 mM EGTA, and 0.5%
bovine serum albumin (BSA)) and immediately homogen-
ized (tissue/isolation buffer ratio, 1:10 w/v). The homoge-
nate was centrifuged at 1000 g, 4 jC, for 10 min to
pellet the cell debris and blood cells. The supernatant was
sequentially centrifuged at 1000 g and 8000 g, each for
10 min. The mitochondrial pellet so obtained was washed
and suspended in isolation buffer (tissue/buffer, 1:1 ratio,
w/v), and mitochondrial aliquots stored at  80 jC. For
the determination of the mitochondrial proteins, mitochon-
drial pellet was suspended in isolation buffer without BSA,
and protein concentration determined by the Bradford
method [30].
Complex IV activity was measured following the oxida-
tion of reduced cytochrome c at 550 nm (extinction
coefficient 19.0 mM 1 cm 1) [31]. For this, mitochondria
(2.5 Ag protein) were permeabilized in 950 Al of assay
buffer (10 mM Tris–HCl pH 7.0, 120 mM KCl) containing
2.5 mM n-duodecyl-h-D-maltoside for 2 min at 37 jC. The
enzymatic reaction was started with 10 AM reduced cyto-
chrome c, and a decrease in absorbance measured on an
UltroSpec 2000 Spectrophotometer (Pharmacia, Peapack,
NJ) at 550 nm for 2 min. The assay was repeated in the
presence of 5 mM KCN to measure the nonspecific changes
in the absorbance.
2.10. Electron microscopy (EM)
Following infection, heart tissue from infected mice
was harvested and fixed in Ito’s fixative (1.25% form-
aldehyde, 2.5% glutaraldehyde, 0.03% CaCl2, and 0.03%
trinitrophenol in 0.05 M cacodylate buffer, pH 7.3) at
room temperature for 1 h and then overnight at 4 jC.
After washing, samples were post-fixed in 1% osmium
tetraoxide for 1 h and en bloc stained with 1% uranyl
acetate in 0.1 M maleate buffer. After dehydration in a
graded series of ethanol, samples were embedded in Poly/
Bed 812 (Polysciences, Warrington, PA). Ultrathin sections
were cut on a Sorvall MT-6000 ultramicrotome (RMC,
Tucson, AZ), stained with uranyl acetate and lead citrate,
and examined in a Philips 201 transmission electron
microscope (Philips Electron Optics, Eindhoven, The
Netherlands) at 60 kV.Fig. 1. The course of T. cruzi infection and replication in mouse hearts.
C3H/HeN mice were infected by intraperitoneal injection with culture-
derived trypomastigotes of T. cruzi (SylvioX10/4 strain, 1106 parasites/
mouse). T. cruzi rDNA-specific PCR was performed for 28 cycles using
total DNA isolated from whole heart tissue of normal and infected mice at
various time intervals post-infection. PCR amplification of T. cruzi rDNA
using total DNA isolated from heart tissue of 10 mice at day 3 (A), 37 (B),
and 110 post-infection (C) is shown. (D) Quantitation of the parasite
burden. The signal from PCR amplification of T. cruzi in heart tissues
harvested during 3–110 dpi was quantitated using a FluorChem Imaging
System.3. Results
3.1. T. cruzi infection and disease development
T. cruzi ribosomal DNA (rDNA)-specific PCR was
performed to evaluate the infection rate, and the blood
and tissue parasite burden in C3H/HeN mice infected with
SylvioX10/4 strain. Mice infected with T. cruzi exhibited a
course of infection and disease development similar to thatobserved in human and other species [2]. The acute phase
was characterized by a consistent increase in blood and
tissue parasitemia that peaked in intensity during 30–45 dpi.
Parasite rDNA was detected as early as day 3 post-infection
in blood and tissue samples (Fig. 1A and D, data not shown)
obtained from all mice injected with T. cruzi trypomasti-
gotes. The peak blood parasite load, indicated by an increase
in parasite-rDNA, was noted at 30 dpi, after which the blood
parasitemia was reduced to below detection level (data not
shown). Maximum parasite burden in the cardiac tissue of
infected mice was detected during days 37–45 post-infec-
tion (Fig. 1B and D). After 80 dpi, a very faint signal for
parasite rDNA (Fig. 1C and D) was detected in infected
murine hearts and was suggestive of control of acute para-
site burden. A similar pattern of amplification of parasite
rDNA was observed in the skeletal tissue of infected mice
(data not shown). Specificity of the PCR reaction was
confirmed by no amplification of the parasite rDNA upon
incubation of T. cruzi or infected mouse DNA with one
primer or normal mouse DNA with both the primers (data
not shown).
Fig. 2. T. cruzi-induced injury in the infected mice. C3H/HeN mice were
infected with T. cruzi (as above). Heart (panels A, C, E, and G) and skeletal
muscle (panels B, D, F, and H) sections for histological analysis were
obtained at 0 (panels A and B), 20 (panels C and D), 40 (panels E and F),
and 120 (panels G and H) days post-infection. All tissues were subjected to
hematoxylin and eosin staining and visualized by light microscopy.
Representative micrographs from 3 independent experiments (3 mice/
group/experiment) are shown. Note the absence of tissue necrosis,
inflammatory cells, and cellular destruction in tissue sections from normal,
healthy mice (Panels A and B). Original magnification: 40 . Arrow in
panel E represents parasite foci.
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mice was assessed on the basis of tissue parasite lesions,
inflammation, and fibrosis. All infected mice exhibitedFig. 3. Clustered expression patterns of myocardial genes in a murine model of T. c
shades of red and green represent elevated and repressed expression, respectively,
Each row represents a cDNA, and columns pertain to data collected at 3, 37, and 1
was adjusted between + 10 and  10 for the sake of clarity of colors. Insignifica
exhibited no change at a particular time-point post-infection in comparison to coparasite foci in the heart tissue (Fig. 2E, marked with arrow)
and skeletal muscle during the acute phase of infection (up
to 45 dpi). Intense infiltration of inflammatory cells either
closely associated with the parasitic lesions or diffused
throughout the tissue was also noticeable in the myocardium
and skeletal muscle of the infected mice during the acute
phase (Fig. 2C–F). After the acute parasite control, parasitic
foci were not detected in all of the tissue sections examined
by histological analysis. Accordingly, the extent of inflam-
mation and associated tissue damage was remarkably
reduced in skeletal muscle of infected mice at 120 dpi
(Fig. 2H). However, infected mice (>100 dpi) continued
to exhibit substantial inflammation and tissue fibrosis and
necrosis in the heart tissue (Fig. 2G), the hallmarks of
chagasic myocarditis. These results demonstrate that C3H
mice infected with SylvioX10/4 strain of T. cruzi provide a
suitable model system to study the molecular changes
associated with chagasic myocarditis.
3.2. Microarray analysis of gene expression revealed a
repression of the murine transcriptome with the onset of the
chagasic disease phase
Microarrays containing a substantial repertoire of known
murine genes were used to evaluate changes in myocardial
gene expression in T. cruzi-infected mice sacrificed at various
time intervals post-infection. On the basis of parasite burden
and pathological changes in the heart tissue of infected mice
(Figs. 1 and 2), the three time points chosen for microarray
analysis represented immediate early (3 dpi), acute (37 dpi),
and chronic (110 dpi) phases of chagasic disease develop-
ment. All arrays were normalized both globally and for the
expression of a 40S rRNA and compared to arrays probed
with RNA extracted from age-matched, normal murine
hearts. Genes that increased or decreased in comparison to
the controls by at least 1.8-fold in three independent experi-
ments were considered differentially expressed.
Out of a total of 1176 genes printed on the arrays, 31, 89,
and 66 genes were differentially regulated in the context of
their expression trends at 3, 37, and 110 dpi, respectively
(Fig. 3, Table 1). Noticeably, all of the differentially
expressed transcripts in the myocardium at 3 dpi were up-
regulated and encoded immune-related or host defense/
stress proteins. During the acute phase (37 dpi), mRNA
species for 77 of the 89 differentially regulated genes were
increased by at least twofold. Of these, 27 transcripts were
increased by >10-fold, and 18 of the 27 transcripts encoded
the immune-related proteins. Out of the 12 transcripts that
were reproducibly repressed at 37 dpi, eight were charac-
terized to encode proteins involved in mitochondrial energyruzi infection and disease development. Normalized data values displayed in
in heart tissue obtained from infected mice relative to normal mouse hearts.
10 dpi. The value for genes whose expression changed by more than 10-fold
nt differential expression values between + 1.8 and  1.8 or the genes that
ntrol normal mice were set at 0 and shown in black.
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expressed genes (>63%) in the myocardium of infected
mice at 110 dpi were repressed relative to normal controls.
The dramatic repression of the host transcriptional response
at 110 dpi was confirmed in four independent experiments,
carried out with RNA isolated from three mice per experi-
ment. After discarding the sequences whose expression was
changed in less than three experiments, we found 42 of the
66 differentially expressed mRNAs were repressed at 110
dpi. Of these, 26 (60%) transcripts have implications in
sustaining the mitochondrial energy metabolism and main-
taining the cytoskeletal and extracellular matrix (ECM)
structure and function.
3.3. Expression of proinflammatory genes is up-regulated in
response to T. cruzi infection
The histological data suggested the infiltration of the
inflammatory infiltrate in T. cruzi-infected murine hearts as
early as 20 dpi that was maintained throughout the infection
and disease period, albeit at different levels (Fig. 2). The
microarray studies provided a molecular imprint of the
immune responses that might be responsible for maintaining
the inflammation in the chagasic heart. IFN-g, IL-1, IL-6, and
TNF-a are well-characterized proinflammatory cytokines
and are known to participate in control of infectious agents
through different immune mechanisms [32]. IFN-g regulates
several aspects of the protective immune responses, including
stimulation of the phagocytic activity of macrophages,
enhancement of antigen presentation through class I and II
MHC molecules, and synchronization of interaction between
T cells and antigen-presenting cells [33,34], through the
activation of a variety of cytokines, chemokines, and cell
ligand and receptor molecules [34]. Accordingly, the imme-
diate early response of the host to T. cruzi infection was
marked with striking up-regulation of the IFN-inducible
molecules (IIMs), including CC chemokines (e.g. MIG,
SCY2), chemokine receptors (CCKR2 and CCKR5), inter-
feron regulatory factors IRF1 and IRF2, and other IFN-
dependent proteins (Fig. 3, Table 1A). The expression of
IIMs was more pronounced at 37 dpi relative to 3 dpi. It is
therefore likely that IFN-regulated cytokines and chemokines
will function as important modulators of the innate immune
responses against T. cruzi and mediate resistance to infection.
Further evidence for the elicitation of an immediate early
response in infected murine heart was provided by the
expression of transcripts for IL-1 (accession #U56773), IL-
6 (accession #X62646) and TNF-a (accession #L24118,
U37522, L26349) induced molecules (IITM). It is interesting
to note that IITMs were consistently expressed throughout
the infection and disease development period. In contrast, the
expression of a majority of transcripts for IIMs subsided
during the disease phase. Considering that the IFN-mediated
immune reactions play an important role in control of the
parasite [35,36], a decrease in the expression of IIMs is
possibly an adaptation mechanism to control the destructiveeffects of the immune responses on the host cellular compo-
nents. However, the consistent expression of IITMs provides
molecular evidence for the persistence of the inflammation in
infected hearts, also noted in histological studies (Fig. 2).
The stage-specific expression of the IIMs and the consistent
up-regulation of the IITMs in T. cruzi-infected mice also
suggest the differential composition of the proinflammatory
responses exhibited at different stages of infection and
disease development in the myocardium.
3.4. Gene expression pattern indicated cardiac remodeling
in T. cruzi-infected murine hearts
Our gene expression studies indicated an imbalance in
the expression of several of the genes that encode ECM
proteins in the myocardium of infected mice relative to
normal hearts (Fig. 3). At the acute infection stage (37 dpi),
the transcripts for proteins that are structural components of
the ECM, including several types of collagens, dystrophy-
dystrophin, fibronectin, thrombospondin 2, osteoglycin, and
drebrin, were elevated (Table 1C). Consequently, transcripts
for the markers of the hypertrophic response [37,38],
including serum amyloid, sialophorin, embryonic atrial
natriuretic factor (ANF), and annexins, were also increased
in T. cruzi-infected mice at 37 dpi (Fig. 3, Table 1B).
Overexpression of these transcripts is indicative of active
reparative and remodeling reactions that might be initiated
in response to myocardial injuries by invading and replicat-
ing parasites.
It is worth noticing that with the onset of the disease
phase (110 dpi) in the myocardium, mRNAs for collagens,
fibronectin, and other ECM proteins were either elevated to
a lesser extent than that observed at 37 dpi or were
substantially repressed (Fig. 3, Table 1C). Additionally,
transcripts for cardiac troponins (T1 and T2) and fast
skeletal troponin were reduced at 110 dpi. The differential
expression of the key sarcomere and cytoskeletal proteins,
including alpha cardiac actin, h myosin, troponins, and
alpha tropomyosin, has previously been suspected in exper-
imental heart failure models and inherited cardiomyopa-
thies [39,40]. Our experiments may not have identified all
of the CCM regulators due to the limited repertoire of the
genes printed on the microarrays and possibly due to the
stringency used in our experiments. However, down-regu-
lation of the cardiac troponins, all of which are members of
the contractile apparatus and essential for ventricular func-
tion, suggests the disruption of the sarcomeric filamentary
system with the development of chagasic disease in
infected mice.
3.5. Gene profiling suggested down-regulation of OXPHOS
pathway in the myocardium of infected mice with disease
development
The most striking feature of the host response to T. cruzi
infection was, perhaps, the repression of a number of tran-
Table 1
Selected genes that were differentially expressed in the myocardium of T.
cruzi-infected mice relative to normal controls
UNIQID Gene name GenBank Days post-infection
accession
number
3 37 110
1A. Immune related proteins
A03e Fas antigen; fasL receptor
precursor; CD95 antigen
M83649 3.8 4 1
A04e Interferon concensus
sequence binding
protein
M32489 1 15 1
A07e Interferon regulatory
factor 1 (IRF1)
M21065 6.7 47 6
A07f Interferon regulatory
factor 2 (IRF2)
J03168 1 5 1
A12i Macrophage migration
inhibitory factor (MIG)
Z23048 4 2.1 2.3
C12h TNF-related apoptosis
inducing ligand (TRAIL)
U37522 10.5 7.5 1.7
D02c CC chemokine receptor
type 2 (CCKR2)
U47035 1 7.6 1
D02e CC chemokine receptor
type 5 (CCKR5)
D83648 1 8 1
D04e Tumor necrosis factor
receptor superfamily
member 1A (TNFRSF1A)
L26349 1 3.9 1.8
E01l Monokine induced by
gamma interferon (MIG)
M34815 25 60 1
E02g Small inducible cytokine
A2 (SCY2)
J04467 1 11 1
E07a Interleukin 1 receptor-
associated kinase
U56773 3.8 1.5 1.7
E07c Interleukin 6 signal
transducer (IL6ST)
X62646 2.5 2 3.6
E14c 47-kDa interferon gamma-
inducible protein
M63630 16.5 50 1
F12i Interferon activated gene
203
AF022371 4 5.3 1
F12j Interferon activated gene
204
M31419 8 12.5 1.8
F12m Interferon-induced protein
with tetratricopeptide
repeats 3 (IFIT3)
L32974 76 89 1
F14m Tumor necrosis factor
induced protein 2
(TNFIP2)
L24118 6.5 14.5 5
1B. Host defense proteins related to oxidative stress
A03n Sialophorin X17018 1 30 1
B02b Serum amyloid A 3 X03479 1 33 1
B03f Heat shock protein 2
(HSJ2)
AF055664 2.8 4.2 1
B03i Peripheral benzodiazepine
receptor (PBdzR)
D21207 1 27 1
C08b Tyrosinase M24560 1  1.7 0
C10h Heat shock 60-kDa protein
(HSP60)
X55023 7.5 1.2 3.5
C11d Anti-oxidant protein 1 M28723 3.2 1.2  3.3
E04d Atrial natriuretic peptide
precursor type B (ANF)
S58667 1 3.5 2
E08i Mitogen-activated protein
kinase kinase 1 (MAPKK1)
L02526 3.1 3 1.7
E12a Annexin A2 D10024 1 4 4.4
F11c Jun zipper-associated 1
protein
AF069519 1 2.1 1.8
UNIQID Gene name GenBank Days post-infection
accession
number
3 37 110
1C. Extracellular matrix/hypertrophy proteins
B08e Fibronectin 1 X93167 1 4  1
B08j Osteoglycin D31951 1 2.6  3.8
B08l Procollagen 1 alpha 1
subunit (COL1A1)
U08020 1 3.6  0.2
B08m Procollagen 1 alpha 2
subunit (COL1A2)
X58251 1 4.7  0.5
B08n Procollagen 3 alpha 1
subunit (COL3A1)
X52046 1 4.4 1.7
B09b Procollagen 5 alpha 2
subunit (COL5A2)
L02918 1 5 1
B09g Thrombospondin 2
(THMB2)
L07803 1 23 18
F07m Drebrin-like U58884 1 3.4 1.4
F07n Muscular
dystrophydystrophin
M68859 4.2 3.4 2.4
F10e Fast skeletal troponin C
(FskTnC)
M57590 1 1  1.8
F10f Cardiac troponin TI
(cTnT1)
U09181 1 1  1.8
F10g Cardiac troponin T2
(cTnT2)
L47549 1 1  3.3
1D. Mitochondrial/energy metabolism
B11k Cytochrome b-558 beta
polypeptide
M31775 2.7 11.1 1.6
B11l Cytochrome b-558 alpha
polypeptide
U43384 1 45 1
B11n Cytochrome c oxidase
polypeptide VIIaH
(COX7aH)
AF037370 1 1  1.8
B12a Cytochrome c oxidase,
subunit VIIaL (COX7aL)
AF037371 1  1.7  3.8
B12b Cytochrome c oxidase
polypeptide VIIc (COX7c)
X52940 1 1  3.3
B12f Cytochrome c oxidase
polypeptide VIaH
(COX6aH)
U08439 1  2.3  2
C02d NADH dehydrogenase
(ubiquinone) 1 alpha
subcomplex 1
Y07708 1  1  2.3
Values for repressed genes are log-transformed. UNIQID was assigned to
individual genes in reference to the position on the array (Clontech).
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drial OXPHOS pathway. With progression of infectious and
disease stages, transcripts encoding polypeptides of
OXPHOS complexes, specifically complex I (NADH-ubiq-
uinone oxidoreductase) and complex IV (cytochrome c
oxidase), were dramatically decreased in the myocardium
of infected mice as compared to normal murine hearts (Fig.
3, Table 1). The repression of mRNAs for OXPHOS
components was detectable at 37 dpi when alterations in
the expression of genes indicative of cardiac remodeling
were also noted. With progression to disease phase (110 dpi)
in the myocardium of infected mice, the extent of down-
regulation of OXPHOS transcripts was further enhanced.
The pathological outcomes of OXPHOS dysfunctions can
play pivotal roles in cardiovascular homeostasis associated
Table 2
Oligonucleotides used in this study
Gene name GenBank accession
number
Forward primer sequence
(5V! 3V)
Reverse primer sequence
(5V! 3V)
Amplicon
(bp)
Mouse
Cardiac troponin T1 (cTnT1) U09181 AGCAGCGATGCGGCTGG CCTGCATCATGGCATCTG 460
Cardiac troponin T2 (cTnT2) L47549 CAGACTCTGATCGAGGC CTCCTCTCTGCCAGGATC 441
Cytochrome c oxidase VIIaH
(COX7aH)
AF037370 GCTCATCTACCAGAAGCC GAAGGAGGCCCAGCCC 185
Cytochrome c oxidase VIIaL
(COX7aL)
AF037371 TGTGCGGAATCTGCTG CAGCCATAGCTAACAG 228
Cytoplasmic h-Actin (h-Ac) M12481 CCAGATCATGTTTGAG GTCCAGACGCAGGATG 170
Fast skeletal troponin C (FskTnC) M57590 GACATGTTCGATGCTGATG CACCTCCTCGATGATGGC 116
Interferon regulatory protein 1 (IRF1) M21065 CCAGCACTGTCACCGTG CAGCAGGCTGTCCATCC 370
Murine 18S rRNA (18S rRNA) X00686 GTACGCACGGCCGGTACAGTG GCGCGCCTGCTGCCTTCC 422
Peripheral benzodiazoepine R (PBdzR) D21207 CTCCGGTGGTATGCTAGC GGCCAGAGTTATCACGCC 390
Procollagen type I alpha 2 (COL1A2) X58251 GGTGCTGCTGGTGCTAC GCCAGGATCACCAGAGG 575
Procollagen type III alpha 1 (COL3A1) X52046 ATGAATTGGGATGCAG CTGTGGGCACATTCTCC 197
Procollagen type V, alpha 2 (COL5A2) L02918 AGTGCCCAGAGGTGCTCAAC CCTGAGGACCACGAGGAC 472
Protein:GPI transamidase (GPI8) CGAGCATTGTCTATGTGCCTTG GTCGCCCACAGATATTATGG 378
Thrombospondin 2 (THMB2) L07803 GCACAGTTACCTGTGCTG CACTCACACTTGTACATGG 524
TNF-inducible protein 2 (TNFIP2) U83903 CAGGTCTGCTACTGGCAC GACGGATGCATCACTCAG 230
T. cruzi
T. cruzi 18S rRNA AF228685 TAGTCATATGCTTGTTTC GCAACAGCATTAATATACGC 645
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ent cellular mechanisms.
3.6. Confirmation of microarray data
In independent experiments, the relative expression of 15
representative genes (listed in Table 2) in the myocardium ofFig. 4. Confirmation of microarray expression data by RT-PCR analysis.
C3H/HeN mice were infected by intraperitoneal injection with culture-
derived trypomastigotes of T. cruzi. Total RNA isolated from whole hearts
of normal and infected mice was used for RT-PCR analysis. First strand
cDNA was synthesized from 2 Ag of the total RNA samples in a 20-Al
reaction. Subsequently, PCR was performed for 28 cycles using 0.5 Al of
the cDNA as template and the gene-specific primers. Abbreviations used:
COX7aH, cytochrome c oxidase subunit 7aH; COX7aL, cytochrome c
oxidase subunit 7aL; cTnT1, cardiac troponin T1; cTnT2, cardiac troponin
T2; COL5A2, procollagen subunit 5A2; TNFIP2, TNF-induced protein 2;
IRF1, interferon regulatory factor; 18S rRNA, 18S ribosomal RNA, GPI8,
glycosylphosphatidylinositol-protein transamidase; and dpi, days post-
infection.the infected mice was analyzed by RT-PCR analysis. These
included COX7aH, COX7aL, cTnT1, cTnT2, and FskTnC,
noted to be repressed with disease progression, in microarray
studies; TNFIP2 and IRF1, induced at 3, 37 and 110 dpi;
COL1A2, COL3A1, COL5A2, THMB2, and PBdzR up-regu-
lated during the acute phase; andmurine 18S rRNA,GPI8, and
b-actin, which exhibited no change in expression in infected
and normal mice. Expression data from nine of these tran-
scripts, representative of each category, are shown in Fig. 4.
Similar to the microarray findings, a significant reduction
in COX7aH and COX7aL transcripts was observed in the
heart tissue of infected mice at 37 and 110 dpi, but not at 3
dpi when compared to control mice. Likewise, transcripts
for cTnT1 and cTnT2 were reduced at 110 dpi. In agreement
with the microarray results, a substantial increase in abun-Fig. 5. Western blotting demonstrates a decrease in the expression of
cytochrome c oxidase subunits in infected murine hearts. Total heart
homogenates from normal (N) or infected mice harvested at 21, 45, 110,
and 330 dpi were resolved by SDS-PAGE. Proteins were transferred to
PVDF membranes, and Western blot analysis conducted using anti-
COX7aH, anti-COX7aL, and anti-h actin as primary antibodies.
Table 3
Cytochrome c oxidase activity is reduced in the myocardium of T. cruzi-
infected mice
Enzyme activity Days post-infection
(nmol/min/mg protein)
0 37 110
Cytochrome c oxidase 543F 66 344F 45 242F 55
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noted in infected mice at 37 dpi; densitometric analysis
suggested a f 2.5-fold increase in COL5A2 and TNFIP2,
and a f 5-fold increase in IRF1 transcripts in infected mice
at day 37 post-infection as compared to that detected at 3
and 110 dpi. Comparable amplification of murine 18S rRNA
and GPI8 transcripts in the heart tissue of infected and
normal mice confirmed the use of equal amounts of total
RNA in cDNA generation and PCR reactions, and sug-
gested no effect of T. cruzi infection on the expression of
GPI8 and 18S rRNA in the myocardium of mice.
Next, we determined whether changes in transcript
abundance correlated with protein expression. Considering
the substantial decrease in transcripts of several complex IV
polypeptides during the disease stage, we decided to exam-
ine the relative abundance of cytochrome c oxidase subunits
in normal and infected murine hearts (Fig. 5). A significant
decrease in COX7aH polypeptide was observed in the
myocardium of infected mice at 110 dpi, the repression
being amplified with chronic disease development (330
dpi). The protein level for COX7aL was decreased early
during the acute phase. Densitometric analysis suggested
>80% reduction in COX7aL levels during 45-330 dpi in
infected murine hearts as compared to normal mice. Similar
levels of the h-actin in all tissue lysates (Fig. 5) confirmedFig. 6. Transmission electron microscopy (EM) of heart tissue from T. cruzi-infec
tissue ultra-thin sections for EM analysis, obtained from infected mice at days 17 a
of an ultra thin heart tissue section from normal, uninfected mouse is shown in pa
stage of infection (Panel A, parasites marked with letter p and arrow), and mitoc
(Panel B, marked with arrow heads) in cardiac myocytes during disease phase (pan
a normal mouse (C). Bar = 1 Am. Original magnification, 9400 .equal loading of the proteins in each lane. Overall, RT-PCR
and Western blot analyses have provided independent con-
firmation of microarray data for the induction and repression
of several of the cardiac genes in response to T. cruzi
infection and disease development.
3.7. Cytochrome c oxidase activity is decreased in the
myocardium of infected mice
Given the alterations in the expression of cytochrome c
oxidase subunits in T. cruzi-infected murine hearts, we
predicted that a deficiency of complex IV activity might
ensue with the development of chagasic disease. To deter-
mine if such is the case, we estimated the enzymatic activity
of cytochrome c oxidase in mitochondria isolated from the
cardiac tissue of normal and infected mice, by spectropho-
tometric assay. As shown in Table 3, mitochondria isolated
from infected mice exhibited substantial decline in complex
IV activity. In comparison to normal controls, cardiac
mitochondria isolated from infected mice showed 40%
and 56% reduction in cytochrome c oxidase activity at days
37 and 110 post-infection, respectively. The decrease in the
complex IV enzymatic activity in infected mice provides
further evidence for the accuracy of microarray data and
suggests that the infected murine hearts might be compro-
mised in terms of mitochondrial OXPHOS capacity with
CCM progression.
3.8. Mitochondrial collapse with the development of
chagasic disease
To illustrate the consequences of the molecular changes
in the expression of ECM and mitochondrial genes inted mice. C3H/HeN mice were infected with T. cruzi (as in Fig. 1). Heart
nd 143 post-infection, are shown in panels A and B, respectively. EM image
nel C. Representative micrographs showing parasites in a myocyte at early
hondrial swelling (Panel B, marked with letter m) and lipid accumulation
el B) are presented. Note the absence of these features in cardiac myocyte of
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the heart tissue by EM, and evaluated the extent of morpho-
logical alterations in the myocardium of infected mice at
various time intervals post-infection. As expected from the
results presented in Figs. 1 and 2, we detected parasites in
the cardiomyocytes upon EM analysis of the tissue sections
harvested from acutely infected mice (Fig. 6A, note the
intracellular amastigotes marked with arrows). During this
stage, a local depletion of the cell cytoplasm adjacent to the
parasites was noted; however, no other injuries were evi-
dent: myofibrils were not damaged; mitochondria had
normal appearance, and linear arrangement of myofibers
and mitochondria was not disturbed (Fig. 6A). With pro-
gression of disease phase, parasites were not detected in all
of the tissue sections obtained from mice sacrificed at 110
and 143 dpi. However, myocardial alterations characterized
by large irregular nuclei, focal myofibrillar degeneration,
and Z-line distortion were evident (Fig. 6B, data not
shown). Additionally, mitochondria were swollen and dis-
placed, and accumulation of lipid droplets alongside the
irregular mitochondria (Fig. 6B, marked with arrows) was
noticeable. These changes were particularly evident when
compared with heart tissue sections obtained from unin-
fected, normal mice (Fig. 6C). Altogether, the results of the
EM studies, suggestive of the loss of the myofibrils and
mitochondrial structure and function in cardiac myocytes of
the chronically infected mice, are consistent with the irreg-
ularities in the expression of ECM and mitochondrial genes,
noted in microarray studies (Fig. 3).4. Discussion
In this study, we profiled the alterations in host gene
expression to gain insight into the molecular mechanisms
underlying the development of chagasic myocarditis. For
this, an experimental murine model of T. cruzi infection was
employed and the changes in cardiac gene expression over
the time period spanning from early infection to the onset of
the disease phase was identified. As recognized in humans,
the course of disease development in C3H/HeN mice
infected with SylvioX10/4 strain of T. cruzi was divided
into (a) the acute infection phase (up to 45 dpi) when a
significant increase in the blood and tissue parasite burden
was noted (Fig. 1), (b) the progressive disease phase marked
by minimal parasite burden in association with extensive
inflammation and cellular fibrosis, and (c) tissue degener-
ation in the myocardium (Figs. 2 and 6). Considering that
the RNA for microarray hybridization was prepared from
whole heart, consisting of infected and uninfected myocytes
and other cell types, the true changes in gene expression in
infected cardiomyocytes may be underestimated in the
present study. Nevertheless, a total of 114 genes was found
to be differentially expressed in the myocardium of infected
mice over the course of disease development. The clustering
of the genes exhibiting similar expression pattern andrelated functional characteristics revealed the molecular
print of the biological processes that are perturbed in the
myocardium of mice during the course of T. cruzi infection
and onset of the disease phase.
The overall expression data suggested two important
phenomena with respect to myocardial composition and
function. One, the coordinated up-regulation of transcripts
for ECM proteins, the increased expression of fetal ANF
mRNA, and the abundance of mRNAs for several tran-
scription and translation factors (Fig. 3, Table 1) occurred at
37 dpi. All of these changes are indicative of increased
matrix deposition and protein synthesis, and suggest the
instigation of hypertrophic response in the myocardium of
acutely infected mice. Second, with the onset of the disease
phase, the infected mice displayed a general deterioration of
the myocardial structure as was evident by the repression of
myofibril transcripts (Figs. 3 and 4) and accumulation of
deformed myofibers separated by distorted Z-lines (Fig. 6).
The data presented in this study provide insights into the
molecular mechanisms that might be responsible for invok-
ing the differential expression of ECM and sarcomeric genes
leading to a multi-faceted outcome, i.e. tissue fibrosis and
hypertrophy, cardiac remodeling, and myocardial degener-
ation of the T. cruzi-induced CCM.
The earliest response detected in T. cruzi-infected mice
was the substantial increase in transcripts representative of
the pro-inflammatory reactions that continued to persist
throughout the infection and disease period (Fig. 3, Table
1A). The prime purpose of the proinflammatory cytokines in
infected mice appears to be related to the control of the
infectious agent. However, TNF-a and IL-1 can also exert
similar biological effects on the host cellular components
through regulation of different autocrine and paracrine
mechanisms. Of note is the role of TNF-a and IL-1 in
NF-nB activation, which evokes cell survival/cell growth
responses through down-regulation of the apoptotic path-
ways [41]. Additionally, TNF-a is also known to induce the
activation of caspases leading to apoptotic cell death [42].
Systemic administration of TNF-a causes irreversible car-
diac depression in both human and experimental models
[43,44]. It is thus reasonable to suggest that the extent of
activation of the pro-apoptotic reactions by inflammatory
responses and the NF-nB-induced anti-apoptotic pathways
would decide the ultimate fate of the myocardial cells in
infected mice; as long as the NF-nB pathway is functional
and active, cells may survive and grow. However, if NFnB
is blocked or the anti-apoptotic pathway is not activated,
then cell death would prevail.
Recent studies have documented the silencing effects of
interferon-regulated factor IRF1 and IRF2 on NFnB-
induced transcriptional activity [45,46]. The demonstration
of up-regulation of IRF1 and IRF2 in our studies (Fig. 3,
Table 1A) suggests that NFnB might be depressed in T.
cruzi-infected mice. Others have shown the cell-specific
effect of T. cruzi infection on NF-nB activation. In isolated
macrophages exposed to T. cruzi, induction of NF-nB tran-
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from skeletal, smooth, and cardiac muscle are the prime site
for intracellular replication of T. cruzi in infected host, and
all of these cell types exhibit no induction of NF-nB in in
vitro infection studies [47]. Whether NFnB inhibition in
cells is mediated through direct interaction of NFnB with
parasite molecules or with IRFs (induced in response to
infection) is not known. Either way, the long-term inhibition
of NFnB would be detrimental to the host, primarily
because of the inability to control cell death as a conse-
quence of parasite infection or inflammation. Up-regulation
of apoptosis-related Fas antigen, in our system, supports this
notion. Taken together, our results imply that persistent
expression of IITMs would play an important role in
promoting apoptotic cell death in chagasic myocarditis.
The most striking response of the host to T. cruzi
infection was the repression of the transcripts for various
components of OXPHOS pathway (Figs. 3 and 4). Sub-
sequently, a reduction in the expression of the complex IV
polypeptides (Fig. 5) and a decline in the cytochrome c
oxidase activity (Table 3) were also noted with disease
development in the myocardium of infected mice. Our
results suggest an overall loss of mitochondrial OXPHOS
capacity in infected mice that can have an adverse influ-
ence on global energy production and subsequent cardiac
performance. This suggestion is supported by the observa-
tions of morphologic abnormalities in mitochondrial struc-
ture associated with a decrease in OXPHOS capacity in
cardiomyocytes of cardiomyopathy patients and experi-
mental models of heart failure [48]. A reduction in high-
energy phosphates has also been reported in the hyper-
trophied and failing hearts [49–51]. Our study is, however,
the first to demonstrate the abnormalities of mitochondrial
morphology and the OXPHOS pathway in chagasic myo-
carditis.
Several lines of evidence indicate that the myocardium of
the infected mice might be exposed to excessive oxidative
stress. A sub-optimal functionality of the OXPHOS com-
plexes causes the release of electron energy to molecular
oxygen and reactive oxygen production. Considering the
high density of mitochondria in cardiomyocytes, OXPHOS
dysfunction can be the major source of reactive oxygen
species (ROS) in myocardium. The immense decrease in the
expression and activity of cytochrome c oxidase (Figs. 3–5,
Table 3) observed in this study suggests that uncoupling of
the OXPHOS pathway and production of increasing
amounts of ROS would occur with cardiac disease pro-
gression in infected mice. Other genes related to ROS
production were also modulated in the myocardium of
infected mice. For example, the levels of cytochrome b-
558 a and h, the subunits of NADH oxidase, were elevated
in infected mice (Table 1D). NADH oxidase is the main
enzyme involved in ROS generation in epithelial tissues.
The transcripts for HSP60, antioxidant protein 1, and
tyrosinase (Table 1B) that participate in different oxidative
stress defense mechanisms were also increased in themyocardium of infected mice. Thus, the distinct expression
profile of the pro- and antioxidant genes might result in an
imbalance between ROS production and free radical scav-
enge. As a result of the impaired redox state, direct
oxidative damage of the cellular components (e.g. proteins,
lipids, and DNA) may accelerate the cardiac injuries [52].
This notion is supported by the observations that acute
injuries resulting in an imbalance between pro- and anti-
oxidants induce apoptosis in cardiomyocytes [53]. The up-
regulation of apoptosis-related Fas antigen transcripts and
the alterations in the expression of ECM and sarcomeric
genes in infected murine hearts can also be related to cell
death. Taken together, our results imply that oxidative stress
is induced in the myocardium of infected mice, and it may
contribute to the pathogenesis of CCM through tissue
injuries and cell death. The detection of a few, if any,
parasites during chronic disease phase suggests that oxida-
tive insult of the infected cells or the intracellular parasite
may also contribute to control of T. cruzi in the infected
myocardium.
Recent studies have suggested that oxidative stress con-
tributes to cardiovascular diseases through activation of a
variety of intracellular signaling pathways. One such relay
system is the superfamily of MAPK. There are at least three
distinct subfamilies (ERK, SAPK/JNK, and p38) of the
MAPK superfamily, all of which can be induced by oxida-
tive stress [54]. The ERKs, in general, activate a cytopro-
tective, anti-apoptotic effect, leading to an increase in
protein synthesis and cell growth [55]. The JNK and p38
cascades can regulate both cell-growth and cell-death pro-
grams, depending upon the activation of downstream trans-
activating/DNA-binding transcription factors [56,57]. In this
model of chagasic myocarditis, depression of the OXPHOS
pathway in the myocardium correlated with alterations in
transcripts for the members of ERK-MAPK super-family
(MAPKK1) and downstream transcription factor c-Jun
(Table 1B). Our results are consistent with others document-
ing the phosphorylation and activation of ERK-MAPKs and
expression of c-jun/c-fos transcription factors upon T. cruzi
infection in experimental models [58], and suggest that
although ROS might be important in initiating tissue injury,
it may also exert protective effects through an ERK-medi-
ated increase in protein synthesis and cell growth in infected
myocardium.
In microarray studies, validation of the results with
methods such as RT-PCR or Northern blotting is necessary.
We have used RT-PCR to confirm the microarray analysis of
expression levels of several of the ECM- and OXPHOS-
related genes during the CCM development. Additionally,
Western blotting and biochemical assays were employed to
further confirm the deficiency of complex IV of OXPHOS
pathway during CCM progression.
In conclusion, the alterations in gene expression
observed in our study provide a new framework for under-
standing the initiation and progression of chagasic myocar-
ditis. Our data suggest the disorders of mitochondrial
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dative stress, produced due to OXPHOS dysfunction or the
up-regulation of other ROS-related genes, may be one of the
key events in progression of CCM, either due to its injurious
effects on cardiac cellular components or through redox
activation of the signaling cascades involved in cardiac
hypertrophy and remodeling responses. Further studies with
mice given antioxidants (e.g. Vitamins A, C, and E cocktail)
in combination with benznidazole (anti-parasite drug) will
determine if the OXPHOS dysfunction-mediated oxidative
stress is a consequence of mitochondrial injuries by the
parasite infection, and whether oxidative stress is the
causative mechanism in the development of CCM. Alter-
natively, it is possible that mitochondrial OXPHOS dys-
function and subsequent oxidative stress is a secondary
response caused by increased expression and activity of
the pro-inflammatory mediators. Studies with mice given
anti-inflammatory agents during the course of disease
development will determine if mitochondrial dysfunction
associated oxidative stress is the downstream effect of
cardiac pathology.
Finally, it is worth mentioning that, in comparison to
isolated fibroblasts that exhibited few changes in gene
expression in response to T. cruzi infection [11], significant
alterations were observed in the expression profile of the
whole heart in this study. Several factors including the
molecular and biochemical changes in infected cardiomyo-
cytes, infiltration of macrophages and inflammatory cells,
and vascular impairment are expected to influence the overall
expression profile of the whole heart. Studies that would
assess the gene expression profile of individual cells or cell
populations isolated from infected hearts will be needed to
deduce the true changes in myocyte gene regulation in
response to T. cruzi infection, and to distinguish the stimuli
or signaling factors originating from infected vs. noninfected
cells that might exert their effects in an autocrine or paracrine
manner in formatting the disease outcome.Acknowledgements
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